We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Binding Site Sells Autoimmune Business to Werfen

By LabMedica International staff writers
Posted on 13 Jul 2009
Binding Site (Birmingham, UK), a privately owned diagnostics company, has sold its autoimmune business to the Werfen Group (Barcelona, Spain). More...
Financial details of the transaction were not disclosed.

The Binding Site autoimmune diagnostics side of the business develops, manufactures, and distributes a range of assays and reagents used in hospital labs worldwide, to help diagnose and monitor the treatment of autoimmune diseases. These include rheumatoid arthritis, antiphospholipid syndrome, vasculitis, and celiac disease.

Binding Site will continue to manufacture autoimmune products on behalf of the Werfen Group, enabling Werfen to continue servicing the Binding Site autoimmune business. The protein business of Binding Site includes Freelite and Hevylite, which will be unaffected by the acquisition.

Paul Duncan, CEO of The Binding Site said, "The Binding Site has built a strong niche in the autoimmune sector. We are confident that a company of the caliber of Werfen will be well placed to continue to deliver the level of quality and service that our customers have come to expect and we look forward to working closely with Werfen and our customers to ensure a smooth transition over the coming months."

Werfen will continue investing in the research and development of early biomarkers, instrumentation and software, which could help in the early diagnosis of diseases.

Related Links:
Binding Site
Werfen Group


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Alzheimer's Disease Biomarker Assay
Elecsys Phospho-Tau (217P) Plasma
Urine Analyzer
respons® UDS100
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: 123RF

Screening After Pneumococcal Disease May Reveal Undiagnosed Blood Cancer or Immune Disorders

Severe pneumococcal disease requiring hospitalization often presents as pneumonia, particularly in older adults and people with cancer or compromised immune function. Because M protein testing and antibody... Read more

Microbiology

view channel
Image Credit: 123RF

FDA-Cleared Multiplex PCR Test Detects 13 Respiratory Pathogens in a Single Sample

Respiratory tract infections can be difficult to distinguish at presentation because many cause overlapping, nonspecific symptoms and are initially grouped as influenza-like illnesses. Causes span a range... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.